Literature DB >> 29222216

Development of forced normalisation psychosis with ethosuximide.

Sean Apap Mangion1, Fergus Rugg-Gunn2.   

Abstract

A 50-year-old man with known multidrug resistant coexistent focal and generalised epilepsy was commenced on ethosuximide, with normalisation of his electroencephalogram and cessation of absence seizures. Within 3 weeks, he developed a rapidly worsening paranoid psychosis with visual and olfactory hallucinations. A month after the cessation of ethosuximide and concurrent treatment with olanzapine, his psychosis resolved and permitted reinitiation of ethosuximide at a lower dose without recurrence of psychotic symptoms. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  clinical neurophysiology; delusional disorder; drugs: cns (not psychiatric); epilepsy and seizures

Mesh:

Substances:

Year:  2017        PMID: 29222216      PMCID: PMC5728201          DOI: 10.1136/bcr-2017-220838

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  21 in total

Review 1.  Forced normalization: clinical and therapeutic relevance.

Authors:  E S Krishnamoorthy; M R Trimble
Journal:  Epilepsia       Date:  1999       Impact factor: 5.864

2.  Block of cloned human T-type calcium channels by succinimide antiepileptic drugs.

Authors:  J C Gomora; A N Daud; M Weiergräber; E Perez-Reyes
Journal:  Mol Pharmacol       Date:  2001-11       Impact factor: 4.436

3.  Vigabatrin-induced forced normalization and psychosis--prolongated termination of behavioral symptoms but persistent antiepileptic effect after withdrawal.

Authors:  Peter Weber; Patricia Dill; Alexandre N Datta
Journal:  Epilepsy Behav       Date:  2012-04-12       Impact factor: 2.937

4.  Forced normalisation precipitated by lamotrigine.

Authors:  Béla Clemens
Journal:  Seizure       Date:  2005-10-05       Impact factor: 3.184

Review 5.  Neuropsychiatric complications of epilepsy.

Authors:  Andres M Kanner; Susan Palac
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

6.  Major Psychiatric Disorders Subsequent to Treating Epilepsy by Vagus Nerve Stimulation.

Authors:  Dietrich Blumer; Keith Davies; Alan Alexander; Stacy Morgan
Journal:  Epilepsy Behav       Date:  2001-10       Impact factor: 2.937

7.  Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam.

Authors:  Christoph Helmstaedter; Yoan Mihov; Mohammad R Toliat; Holger Thiele; Peter Nuernberg; Susanne Schoch; Rainer Surges; Christian E Elger; Wolfram S Kunz; René Hurlemann
Journal:  Epilepsia       Date:  2012-08-06       Impact factor: 5.864

8.  Catatonic psychosis related to forced normalization in a girl with Dravet's syndrome.

Authors:  Giuseppe Gobbi; Simona Giovannini; Antonella Boni; Paola Visconti; Massimiliano Beghi; Cesare Maria Cornaggia
Journal:  Epileptic Disord       Date:  2008-12       Impact factor: 1.819

Review 9.  Antiepileptic drugs and psychopathology of epilepsy: an update.

Authors:  Marco Mula; Francesco Monaco
Journal:  Epileptic Disord       Date:  2009-03-03       Impact factor: 1.819

10.  Developmental changes in human dopamine neurotransmission: cortical receptors and terminators.

Authors:  Debora A Rothmond; Cynthia S Weickert; Maree J Webster
Journal:  BMC Neurosci       Date:  2012-02-15       Impact factor: 3.288

View more
  1 in total

Review 1.  Effects of antiseizure medications on alternative psychosis and strategies for their application.

Authors:  Yin Yan; Jun-Hong Wu; Xiao-Yan Peng; Xue-Feng Wang
Journal:  World J Psychiatry       Date:  2022-04-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.